MX9306930A - Peptidos inhibidores de las tirosina cinasas y sususos terapeuticos. - Google Patents
Peptidos inhibidores de las tirosina cinasas y sususos terapeuticos.Info
- Publication number
- MX9306930A MX9306930A MX9306930A MX9306930A MX9306930A MX 9306930 A MX9306930 A MX 9306930A MX 9306930 A MX9306930 A MX 9306930A MX 9306930 A MX9306930 A MX 9306930A MX 9306930 A MX9306930 A MX 9306930A
- Authority
- MX
- Mexico
- Prior art keywords
- sususes
- therapeutic
- kinase inhibitors
- peptides
- tyrosine
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical group 0.000 abstract 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102000001301 EGF receptor Human genes 0.000 abstract 1
- 108060006698 EGF receptor Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000015439 Phospholipases Human genes 0.000 abstract 1
- 108010064785 Phospholipases Proteins 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 230000026731 phosphorylation Effects 0.000 abstract 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona nuevos compuestos peptídicos y composiciones farmacéuticas que contienen los compuestos, útiles como agentes farmaco-lógicos en el control de enfermedad hiperproliferativa, tal como cáncer y en el tratamiento de enfermedades virales, inflamatorias, alérgicas y cardiovasculares. Los péptidos en la forma de sal que no están en la forma de sal, comprende un sitio de fosforilación de la tirosina de la fosfolipasa C-Ó1 (PLC-Ó1) en el que la tirosina es modificada, de tal manera que en un proceso celular, el péptido inhibe al receptor EGF de la tirosina cinasa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97313692A | 1992-11-06 | 1992-11-06 | |
| US13991393A | 1993-10-27 | 1993-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9306930A true MX9306930A (es) | 1994-08-31 |
Family
ID=26837664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9306930A MX9306930A (es) | 1992-11-06 | 1993-11-05 | Peptidos inhibidores de las tirosina cinasas y sususos terapeuticos. |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5548694A (es) |
| MX (1) | MX9306930A (es) |
| WO (1) | WO1994011392A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6066463A (en) * | 1993-09-28 | 2000-05-23 | New York University | Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders |
| US6107457A (en) * | 1995-02-16 | 2000-08-22 | Board Of Regents, The University Of Texas System | Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| US6133419A (en) * | 1996-11-01 | 2000-10-17 | Onyx Pharmaceuticals, Inc. | Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
| FR2844452A1 (fr) * | 2002-09-18 | 2004-03-19 | Inst Gustave Roussy Igr | Utilisation d'inhibiteurs specifiques de tyrosine kinases pour l'immunomodulation |
| CA3233983A1 (en) * | 2021-11-02 | 2023-05-11 | Ole-Jan Iversen (Deceased) | Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587657D1 (de) * | 1984-01-30 | 1993-12-23 | Imp Cancer Res Tech | Verbesserungen an wachstumsfaktoren. |
-
1993
- 1993-11-03 AU AU55486/94A patent/AU5548694A/en not_active Abandoned
- 1993-11-03 WO PCT/US1993/010610 patent/WO1994011392A1/en not_active Ceased
- 1993-11-05 MX MX9306930A patent/MX9306930A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994011392A1 (en) | 1994-05-26 |
| AU5548694A (en) | 1994-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20120007A (es) | 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728) | |
| UY26968A1 (es) | Agentes terapéuticos | |
| ID22746A (id) | Senyawa-senyawa baru | |
| AR007856A1 (es) | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina, quinasa, sus metodos de prepraracion, intermediarios, uso en medicina ycomposiciones farmaceuticas que los contienen | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| PT735818E (pt) | Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y | |
| ATE267200T1 (de) | Bicyclische kinase inhibitoren | |
| ES2170104T3 (es) | Inhibidores de la produccion de proteinas de beta-amiloide. | |
| AR007857A1 (es) | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen. | |
| AR017588A1 (es) | Compuestos de benzotiazol, inhibidores de la proteina tirosina quinasa, metodo para tratar desordenes asociados con dicha proteina, y las composicionesfarmaceuticas que contienen dichos compuestos | |
| AR009985A1 (es) | Aminotiofencarboxamidas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen, y un procedimiento para obtener estas preparaciones farmaceuticas | |
| AR008853A1 (es) | Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| DE59007531D1 (de) | Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen. | |
| FI944802A0 (fi) | HLE-proteiinien aktiivisuutta inhiboivat laktaamidipeptidit | |
| ES2090081T3 (es) | Derivados de indolocarbazol, procedimientos para su obtencion y su empleo. | |
| MX9306930A (es) | Peptidos inhibidores de las tirosina cinasas y sususos terapeuticos. | |
| DK0417003T3 (da) | Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| PT762883E (pt) | Piridilbisfosfonatos utilizaveis como agentes terapeuticos | |
| UY26911A1 (es) | Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa | |
| BR0209332A (pt) | Derivados de ftalazina com atividade inibidora da angiogênese | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| MX9400072A (es) | Agentes antiinflamatorios derivados de difluoropentapeptido. | |
| ES2188909T3 (es) | Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os |